Wiley and The European Academy of Allergy and Clinical Immunology (EAACI) are to expand their publishing partnership to include EAACI’s official open access journal Clinical and Translational Allergy (CTA) alongside their other publications, Allergy and Pediatric Allergy and Clinical Immunology, as of January 2021.

Clinical and Translational Allergy (CTA) is a fully open access journal, edited by Prof. Jean Bousquet and Dr. Clive Grattan, and provides a dissemination of allergy research and reviews, as well as EAACI position papers, task force reports, and guidelines for an international scientific audience.

Authors of Clinical and Translational Allergy (CTA) will benefit from the many unique Wiley Open Access funder’s agreements. These may help authors submitting to Clinical and Translational Allergy with their open access Article Publication Charges (APCs) in full or in part. To learn more about the Wiley Open Access Accounts visit Wiley Author Services.

“We are delighted to extend our collaboration with Wiley to include CTA in the coming year. Having all three journals under the same publishing umbrella will allow them to benefit from Wiley's extensive expertise in the publishing process, while at the same time keeping up the high quality of EAACI's scientific content, including the most relevant progress and updates in the field." Tomàs Chivato, EAACI VP Science; Jean Bousquet, CTA Editor-in-Chief; Clive Grattan, CTA Editor-in-Chief.